CYP
CYNATA THERAPEUTICS LIMITED
$0.0110
0.00%
Market cap
$3M
Turnover
$9,735
Last price
$0.0110
Day change
0.00%
Announcements
16
Range, past year
Open 0.210 · Low 0.010 · Now 0.011 · High 0.435
Open CYP in the full dashboard →
Charts, screener, momentum and signals across every ASX-listed code.
CYP momentum and trend analysis
Our analysis
Independent analysis generated by Stock Trade Intelligence
as at 2026-09-28.
Momentum quality
30/100
Wyckoff phase
Accumulation53d
Trend stage
Neutral
1 Day
+0.0%
1 Week
+0.0%
1 Month
+0.0%
RSI
28
Avg daily range
4.6%
CYNATA THERAPEUTICS LIMITED scores 30 out of 100 for momentum quality, a reading rated very low confidence. The score weighs trend structure, price consistency, volume backing and how long the move has held, so a high reading means a sustained trend rather than a single large day. Its trend is currently classified as Neutral.
On the Wyckoff cycle it sits in Accumulation, where it has been for 53 trading days. The weekly timeframe reads Downtrend, which does not yet agree with the daily view.
Against the wider market it is currently matching and the institutional accumulation signal reads low.
Points to watch
- RSI oversold (28)
- 60d drawdown -33.3%
- Thin liquidity
- Risk rating: High
- Composite downside risk elevated
CYP announcements
Recent price-sensitive releases.
- 2026-09-24 Notification under Listing Rule 4.3D Periodic Reports - Other | Company Administration - Other
- 2026-08-31 Appendix 4E & Preliminary Final Report Preliminary Final Report
- 2026-07-30 June 2026 Quarterly Activity Report & Appendix 4C Commitments Test Entity - Fourth Quarter Activity Report | Commitments Test Entity - Fourth Quarter Cashflow Report
- 2026-07-06 Board, Management Changes, Expenditure Reductions, RDTI Loan
- 2026-06-19 CYP-004 Osteoarthritis Trial Results
- 2026-06-19 Reinstatement to Official Quotation
- 2026-06-17 CYP-001 GvHD Trial Primary Evaluation Results
More Health Care stocks
Most traded in the same sector.